UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Clinical gastroenterology and hepatology, 2011, Vol.9 (1), p.30-35

2011

Volltextzugriff (PDF)

Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: A pilot study

World journal of gastroenterology : WJG, 2010-05, Vol.16 (19), p.2396-2400

2010

Volltextzugriff (PDF)

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study

Journal of Crohn's and colitis, 2016-08, Vol.10 (8), p.913-924

2016

Volltextzugriff (PDF)

The long journey of salicylates in ulcerative colitis: The past and the future

Journal of Crohn's and colitis, 2009-09, Vol.3 (3), p.149-156

2009

Volltextzugriff (PDF)

Biological agents for ulcerative colitis: Hypes and hopes

Medicinal research reviews, 2008-03, Vol.28 (2), p.201-218

2008

Volltextzugriff (PDF)

Budesonide: teaching an old dog new tricks for inflammatory bowel disease treatment

Current medicinal chemistry, 2008-10, Vol.15 (24), p.2527-2535

2008

Volltextzugriff (PDF)

Medical Therapy for Crohn’s Disease: Top-Down or Step-Up?

Digestive diseases (Basel), 2007-01, Vol.25 (3), p.260-266

2007

Volltextzugriff (PDF)

Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II

Journal of Crohn's and colitis, 2009-12, Vol.3 (4), p.257-263

2009

Volltextzugriff (PDF)

Oral beclomethasone: a review of its use in inflammatory bowel disease

Mini reviews in medicinal chemistry, 2008-12, Vol.8 (14), p.1459-1463

2008

Volltextzugriff (PDF)

Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance

Current medicinal chemistry, 2007-06, Vol.14 (14), p.1489-1497

2007

Volltextzugriff (PDF)

The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man

Digestive diseases (Basel), 2015-01, Vol.33 (Suppl 1), p.113-119

2015

Volltextzugriff (PDF)

Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases

Digestive and liver disease, 2013-07, Vol.45 (7), p.552-555

2013

Volltextzugriff (PDF)

Frequency and Cause of Persistent Symptoms in Celiac Disease Patients on a Long-term Gluten-free Diet

Journal of clinical gastroenterology, 2016-03, Vol.50 (3), p.239-243

2016

Volltextzugriff (PDF)

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel

Journal of Crohn's & colitis, 2013-11, Vol.7 (10), p.820-826

2013

Volltextzugriff (PDF)

Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort

Journal of Crohn's and colitis, 2014-10, Vol.8 (10), p.1217-1221

2014

Volltextzugriff (PDF)

Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review

Journal of Crohn's and colitis, 2011-12, Vol.5 (6), p.619-622

2011

Volltextzugriff (PDF)

Another paradox in Crohn's disease: New onset of psoriasis in a patient receiving tumor necrosis factor‐α antagonist

Inflammatory bowel diseases, 2007-08, Vol.13 (8), p.1059-1061

2007

Volltextzugriff (PDF)

Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs

Rheumatology international, 2010-05, Vol.30 (7), p.977-978

2010

Volltextzugriff (PDF)

Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception

Inflammatory bowel diseases, 2008-03, Vol.14 (3), p.435-436

2008

Volltextzugriff (PDF)

Cancer in Crohn's Disease patients treated with infliximab: A long‐term multicenter matched pair study

Inflammatory bowel diseases, 2011-03, Vol.17 (3), p.758-766

2011

Volltextzugriff (PDF)

Su1266 Characterization of Incident Cases of Cancer in Inflammatory Bowel Disease: A Prospective Multicenter Nested Case-Control IG-IBD Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-455-S-456

2015

Volltextzugriff (PDF)

Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor [alpha] inhibitors and conventional immunosuppressive drugs

Rheumatology international, 2010-05, Vol.30 (7), p.977

2010

Volltextzugriff (PDF)

Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor Delta a inhibitors and conventional immunosuppressive drugs

Rheumatology international, 2010-05, Vol.30 (7), p.977-978

2010

Volltextzugriff (PDF)

Monthly and Seasonal Birth Patterns and the Occurrence of Crohn's Disease

The American journal of gastroenterology, 2009-06, Vol.104 (6), p.1608-1609

2009

Volltextzugriff (PDF)

Internet use among inflammatory bowel disease patients: an Italian multicenter survey

European journal of gastroenterology & hepatology, 2009-09, Vol.21 (9), p.1036-1041

2009

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(52)
Berichte
(5)

Sprache

Englisch
(56)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Humans
(31)
Gastroenterology & Hepatology
(25)
Adult
(17)
Female
(16)
Male
(16)
Aged
(14)
Middle Aged
(14)
Crohn's Disease
(10)
Crohn Disease - Drug Therapy
(9)
Tumor Necrosis Factor-Alpha - Antagonists & Inhibitors
(9)
Infliximab
(8)
Young Adult
(8)
Antibodies, Monoclonal - Therapeutic Use
(7)
Gastroenterology And Hepatology
(7)
Adolescent
(6)
Biological And Medical Sciences
(6)
Inflammatory Bowel Disease
(6)
Medical Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: A pilot study

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study

The long journey of salicylates in ulcerative colitis: The past and the future

Biological agents for ulcerative colitis: Hypes and hopes

Budesonide: teaching an old dog new tricks for inflammatory bowel disease treatment

Medical Therapy for Crohn’s Disease: Top-Down or Step-Up?

Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II

Oral beclomethasone: a review of its use in inflammatory bowel disease

Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance

The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man

Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases

Frequency and Cause of Persistent Symptoms in Celiac Disease Patients on a Long-term Gluten-free Diet

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel

Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort

Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review

Another paradox in Crohn's disease: New onset of psoriasis in a patient receiving tumor necrosis factor‐α antagonist

Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs

Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception

Cancer in Crohn's Disease patients treated with infliximab: A long‐term multicenter matched pair study

Su1266 Characterization of Incident Cases of Cancer in Inflammatory Bowel Disease: A Prospective Multicenter Nested Case-Control IG-IBD Study

Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor [alpha] inhibitors and conventional immunosuppressive drugs

Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor Delta a inhibitors and conventional immunosuppressive drugs

Monthly and Seasonal Birth Patterns and the Occurrence of Crohn's Disease

Internet use among inflammatory bowel disease patients: an Italian multicenter survey

Suchergebnisse filtern